Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.140
-0.005 (-0.23%)
At close: Aug 7, 2025, 4:00 PM
2.140
0.00 (0.00%)
Pre-market: Aug 8, 2025, 7:18 AM EDT
The Aaron's Company Market Cap
Innate Pharma has a market cap or net worth of $195.95 million as of August 8, 2025. Its market cap has increased by 8.78% in one year.
Market Cap
195.95M
Enterprise Value
138.06M
1-Year Change
8.78%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $195.95M, an increase of 56.49%. That is a compound annual growth rate of 3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 195.95M | 18.34% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.93B |
| Johnson & Johnson | 411.69B |
| AbbVie | 344.94B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| Abbott Laboratories | 227.29B |
| UnitedHealth Group | 226.14B |
| Novo Nordisk | 210.71B |